Correlation Between Tandem Diabetes and Cytek Biosciences

Can any of the company-specific risk be diversified away by investing in both Tandem Diabetes and Cytek Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tandem Diabetes and Cytek Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tandem Diabetes Care and Cytek Biosciences, you can compare the effects of market volatilities on Tandem Diabetes and Cytek Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tandem Diabetes with a short position of Cytek Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tandem Diabetes and Cytek Biosciences.

Diversification Opportunities for Tandem Diabetes and Cytek Biosciences

-0.07

Correlation Coefficient

Tandem Diabetes  Cytek Biosciences

Good diversification

The 3 months correlation between Tandem and Cytek is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Tandem Diabetes Care and Cytek Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cytek Biosciences and Tandem Diabetes is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tandem Diabetes Care are associated (or correlated) with Cytek Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cytek Biosciences has no effect on the direction of Tandem Diabetes i.e., Tandem Diabetes and Cytek Biosciences go up and down completely randomly.

Pair Corralation between Tandem Diabetes and Cytek Biosciences

Given the investment horizon of 90 days Tandem Diabetes Care is expected to generate 0.71 times more return on investment than Cytek Biosciences. However, Tandem Diabetes Care is 1.4 times less risky than Cytek Biosciences. It trades about 0.05 of its potential returns per unit of risk. Cytek Biosciences is currently generating about -0.08 per unit of risk. If you would invest  3,063  in Tandem Diabetes Care on November 28, 2024 and sell it today you would earn a total of  203.00  from holding Tandem Diabetes Care or generate 6.63% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Tandem Diabetes Care  vs.  Cytek Biosciences

Tandem Diabetes Care

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Tandem Diabetes Care are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating fundamental indicators, Tandem Diabetes may actually be approaching a critical reversion point that can send shares even higher in March 2025.

Cytek Biosciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Cytek Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's forward-looking signals remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Tandem Diabetes and Cytek Biosciences

The main advantage of trading using opposite Tandem Diabetes and Cytek Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tandem Diabetes position performs unexpectedly, Cytek Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cytek Biosciences will offset losses from the drop in Cytek Biosciences' long position.

The idea behind Tandem Diabetes Care and Cytek Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.